Katena

Tampa, United States Founded: 1975 • Age: 51 yrs Acquired By Corza
Ophthalmic surgical instrument manufacturer

About Katena

Katena is a Healthcare company based in Tampa (United States) founded in 1975, and was acquired by Corza in December 2021. Ophthalmic surgical instrument manufacturer. Katena has raised $7.5 million across 1 funding round from investors including Corza, Audax Group and Cortec Group. The company has 145 employees. Katena has completed 7 acquisitions, including Asico, Blink Medical and Eagle Vision. Katena offers products and services including Reusable Instruments, Single-Use Instruments, Lenses, Biologics, and Microsurgical Knives. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is Katena Products, Inc. Its competitors include Bausch & Lomb and Katalyst Surgical; 1 of its 2 listed competitors has raised funding.

Company details

Katena is a medical device company that develops and manufactures ophthalmic surgical instrumentation. Offers its products to 7k customers around the world. Has done partnership with IOP, another company serving ophthalmic market.

  • Headquarters Tampa, United States
  • Employees 145
  • Stage Acquired
  • Sectors
    Healthcare
  • Website katena.com
  • Social LinkedIn
  • Acquired by Corza (Dec 2021)
  • Legal Name Katena Products, Inc.
Operational Areas
Key Metrics
  • Total Equity Funding
    $7.5M (USD)

    in 1 rounds

  • Latest Funding Round
    $7.5M (USD), Series A

    Dec 2013

  • Investors
    Corza

    & 2 more

  • Employee Count
    145
  • Investments & Acquisitions
    Asico

    & 6 more

  • Acquired by
    Corza

    & 2 more

    (Dec 2021)

Products & Services of Katena

Katena offers a comprehensive portfolio of products and services, including Reusable Instruments, Single-Use Instruments, Lenses, Biologics, and Microsurgical Knives.

Reusable Instruments
Surgical Tools

High-quality instruments for repeated use in ophthalmic procedures

Single-Use Instruments
Disposable Medical Devices

Instruments designed for one-time use to maintain sterility

Lenses
Diagnostic Devices

Optical lenses for surgical and diagnostic eye care applications

Biologics
Therapeutic Products

Biological materials for enhancing ophthalmic surgery outcomes

Microsurgical Knives
Precision Tools

Knives for detailed microsurgical procedures in ophthalmology

Funding Insights of Katena

Katena has successfully raised a total of $7.5M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.5 million completed in December 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $7.5M
  • Total Rounds 1
  • Last Round Series A β€” $7.5M
  • First Round $7.5M

    (Dec 2013)

All 1 funding rounds of Katena with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2013$7.5MSeries A––
–
Valuation history

3 investors in total: 3 institutional.

Investors in Katena

Katena has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Corza, Audax Group and Cortec Group.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
cortecgroup.com
Provides medical devices and surgical instruments for global healthcare providers.
2021corza.comWestwood, United States
Audax Group is focused on supporting middle market companies.
1999audaxgroup.comBoston, United States
Premium access

Investor details for Katena

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Katena

9 people are tracked at Katena (9 in leadership); the tracked headcount is 145.

NameRoleGroup
Steve Blazejewski
CEOLeadership
Bryan Weinmann
Vice President, QA/RALeadership
Carolyn Zdenek
Vice President, OperationsLeadership
Julie Eigenrauch
Director, Human ResourcesLeadership
Arun Mohan
Vice President, Global MarketingLeadership
Roger Tyler
Managing Director, Blink MedicalLeadership
Jack Simmons
Vice President, Global SalesLeadership
Nauman Chughtai
Vice President, Information TechnologyLeadership
Bob Earley
Chief Financial OfficerLeadership
Premium access

Complete people profiles for Katena

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Katena

Katena has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Asico, Blink Medical and Eagle Vision.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Ophthalmic surgical devices such as calipers and cannulas are developed.
asico.comWestmont, United States1983Apr 2021β€’β€’β€’β€’
Surgical instruments are manufactured for medical applications worldwide.
microselectinstruments.comUnited States2005Oct 2020β€’β€’β€’β€’
Handheld ophthalmological diagnostic devices are designed and marketed.
micromedinc.comCalabasas, United States1990Nov 2019β€’β€’β€’β€’
Medical and surgical supplies are distributed by Blink Medical.
blinkmedical.comSolihull, United Kingdom2011Jul 2018β€’β€’β€’β€’
Injection molding and packaging services are provided for medical applications.
nupakmedical.comSan Antonio, United States1997Jul 2017β€’β€’β€’β€’
Ophthalmic devices are manufactured for eye care applications.
eaglevis.comMemphis, United States2016Oct 2016β€’β€’β€’β€’
Ophthalmic devices for glaucoma, oculoplastics, and ocular surface are developed.
iopinc.comCosta Mesa, United States1988Jun 2009β€’β€’β€’β€’
Premium access

Complete acquisition details for Katena

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Katena

12 dated milestones of Katena across 46 years, from founding to its latest funding, stage changes and deals.

  1. Founded Katena is founded.
  2. Acquisition Acquires Innovative Ophthalmic Products.
  3. Exit Acquired by Cortec Group.
  4. Funding First funding round of $7.5M.
  5. Exit Acquired by Audax Group.
  6. Acquisition Acquires Eagle Vision.
  7. Acquisition Acquires NuPak Medical.
  8. Acquisition Acquires Blink Medical.
  9. Acquisition Acquires MicroMedicalDevices.
  10. Acquisition Acquires Micro-Select Instruments.
  11. Acquisition Acquires Asico.
  12. Exit Acquired by Corza.

Competitors of Katena

Katena has 2 listed competitors in our database, 1 of them funded. They include Bausch & Lomb and Katalyst Surgical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bausch.com1853Bridgewater, United States1,681
Ophthalmic pharmaceuticals and instruments are developed for eye care.
katalystsurgical.com2010St. Louis, United States$340,00053
Titanium ophthalmic surgical instruments are manufactured and repaired.
Premium access

Detailed competitors of Katena

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Katena

Websites that share an audience with Katena (katena.com).

Similar websites

Websites whose visitors overlap most with Katena. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
device.com.au
100%
12.7K#1,904,218View details
amblersurgical.com
amblersurgical.com
100%
#1,192,395–
west-op.com
west-op.com
99%
–
surgipro.com
surgipro.com
97%
#2,953,335–
ocusoft.com
97%
21.8K#1,206,704View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 21 similar websites and full traffic analytics for Katena

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 21 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Ophthalmology

3 companies that operate in the same segment as Katena (Ophthalmology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of a wide range of eye care products
1945Fort Worth, Texas, United StatesUSD 171.61 MUSD 24.69 B25,941
Genetic medicines are developed by 4DMT for transformative therapies.
2013Emeryville, California, United StatesUSD 186.59 MUSD 85.21 M227
Developer of antibodies to treat complement-mediated neurodegenerative diseases
2011San Francisco, California, United StatesUSD 256 M100
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Katena

Premium access

Complete news archive for Katena

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Katena

Katena was founded in 1975 and raised its 1st funding round 38 years after it was founded.

Katena is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.

Katena is a funded company, having raised a total of $7.5M across 1 funding round to date. The company's 1st funding round was a Series A of $7.5M, raised on Dec 2013.

Katena has 145 employees.

Katena is a medical device company that develops and manufactures ophthalmic surgical instrumentation. Offers its products to 7k customers around the world. Has done partnership with IOP, another company serving ophthalmic market.

Katena's top competitors include Bausch & Lomb and Katalyst Surgical.

Katena offers Reusable Instruments, Single-Use Instruments, Lenses, Biologics, and Microsurgical Knives.

Katena has made 7 acquisitions, including Asico, Blink Medical, and Eagle Vision.

Katena has 3 investors. Key investors include Corza, Audax Group, and Cortec Group.

Katena operates through Katena Products, Inc..

Yes. Katena was acquired by Corza in December 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available